{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T09:41:32Z","timestamp":1790242892309,"version":"4.1.0"},"reference-count":33,"publisher":"The Endocrine Society","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,9,1]]},"DOI":"10.1210\/jc.2009-0837","type":"journal-article","created":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T02:23:49Z","timestamp":1246415029000},"page":"3558-3566","source":"Crossref","is-referenced-by-count":91,"title":["Increased 5\u03b1-Reductase Activity and Adrenocortical Drive in Women with Polycystic Ovary Syndrome"],"prefix":"10.1210","volume":"94","author":[{"given":"Dimitra A.","family":"Vassiliadi","sequence":"first","affiliation":[{"name":"Centre for Endocrinology, Diabetes, and Metabolism (D.A.V., B.A.H., J.W.T., W.A., P.M.S.), University of Birmingham, Edgbaston, Birmingham B15 2TT, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas M.","family":"Barber","sequence":"additional","affiliation":[{"name":"Oxford Centre for Diabetes, Endocrinology, and Metabolism (T.M.B., M.I.M., J.A.H.W.), University of Oxford, Oxford OX3 7LJ, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beverly A.","family":"Hughes","sequence":"additional","affiliation":[{"name":"Centre for Endocrinology, Diabetes, and Metabolism (D.A.V., B.A.H., J.W.T., W.A., P.M.S.), University of Birmingham, Edgbaston, Birmingham B15 2TT, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark I.","family":"McCarthy","sequence":"additional","affiliation":[{"name":"Oxford Centre for Diabetes, Endocrinology, and Metabolism (T.M.B., M.I.M., J.A.H.W.), University of Oxford, Oxford OX3 7LJ, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A. H.","family":"Wass","sequence":"additional","affiliation":[{"name":"Oxford Centre for Diabetes, Endocrinology, and Metabolism (T.M.B., M.I.M., J.A.H.W.), University of Oxford, Oxford OX3 7LJ, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Franks","sequence":"additional","affiliation":[{"name":"Institute of Reproductive and Developmental Biology (S.F.), Imperial College London, London W12 0NN, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Nightingale","sequence":"additional","affiliation":[{"name":"Wellcome Trust Clinical Research Facility (P.N.), University Hospital Birmingham, National Health Service Foundation Trust, Birmingham B15 2PR, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy W.","family":"Tomlinson","sequence":"additional","affiliation":[{"name":"Centre for Endocrinology, Diabetes, and Metabolism (D.A.V., B.A.H., J.W.T., W.A., P.M.S.), University of Birmingham, Edgbaston, Birmingham B15 2TT, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wiebke","family":"Arlt","sequence":"additional","affiliation":[{"name":"Centre for Endocrinology, Diabetes, and Metabolism (D.A.V., B.A.H., J.W.T., W.A., P.M.S.), University of Birmingham, Edgbaston, Birmingham B15 2TT, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul M.","family":"Stewart","sequence":"additional","affiliation":[{"name":"Centre for Endocrinology, Diabetes, and Metabolism (D.A.V., B.A.H., J.W.T., W.A., P.M.S.), University of Birmingham, Edgbaston, Birmingham B15 2TT, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"key\n\t\t\t\t2019041114174497400_R1","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1056\/NEJMra041536","article-title":"Polycystic ovary syndrome.","volume":"352","author":"Ehrmann","year":"2005","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041114174497400_R2","first-page":"2434","article-title":"A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain.","volume":"85","author":"Asuncio\u0301n","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114174497400_R3","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1210\/jcem.84.11.6148","article-title":"A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile.","volume":"84","author":"Diamanti-Kandarakis","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114174497400_R4","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/0140-6736(90)90664-Q","article-title":"5\u03b1-Reductase activity in polycystic ovary syndrome.","volume":"335","author":"Stewart","year":"1990","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2019041114174497400_R5","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1056\/NEJM199402173300703","article-title":"Hyperandrogenism in polycystic-ovary-syndrome\u2014evidence of dysregulation of 11\u03b2-hydroxysteroid dehydrogenase.","volume":"330","author":"Rodin","year":"1994","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041114174497400_R6","first-page":"2414","article-title":"5 \u03b1-Reductase activity in women with polycystic ovary syndrome.","volume":"84","author":"Jakimiuk","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114174497400_R7","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1515\/JPEM.2000.13.3.253","article-title":"Increased 5\u03b1-reductase and normal 11 \u03b2-hydroxysteroid dehydrogenase metabolism of C19 and C21 steroids in a young population with polycystic ovarian syndrome.","volume":"13","author":"Chin","year":"2000","journal-title":"J Pediatr Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114174497400_R8","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1210\/jc.2002-021875","article-title":"Beyond adrenal and ovarian androgen generation: increased peripheral 5\u03b1-reductase activity in women with polycystic ovary syndrome.","volume":"88","author":"Fassnacht","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114174497400_R9","doi-asserted-by":"crossref","first-page":"5907","DOI":"10.1210\/jc.2003-030240","article-title":"Altered cortisol metabolism in polycystic ovary syndrome: insulin enhances 5\u03b1-reduction but not the elevated adrenal steroid production rates.","volume":"88","author":"Tsilchorozidou","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114174497400_R10","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1210\/jcem.83.5.4951","article-title":"Obesity and gender influence cortisol secretion and metabolism in man.","volume":"83","author":"Andrew","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114174497400_R11","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome.","volume":"81","year":"2004","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t2019041114174497400_R12","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1046\/j.1365-2265.1996.00853.x","article-title":"Urinary free cortisone and the assessment of 11 \u03b2-hydroxysteroid dehydrogenase activity in man.","volume":"45","author":"Palermo","year":"1996","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041114174497400_R13","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and \u03b2-cell function from fasting plasma glucose and insulin concentrations in man.","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"key\n\t\t\t\t2019041114174497400_R14","first-page":"1022","article-title":"Cortisol metabolism in human obesity: impaired cortisone\u2192cortisol conversion in subjects with central adiposity.","volume":"84","author":"Stewart","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114174497400_R15","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.2337\/db08-0094","article-title":"Reduced glucocorticoid production rate, decreased 5\u03b1-reductase activity, and adipose tissue insulin sensitization after weight loss.","volume":"57","author":"Tomlinson","year":"2008","journal-title":"Diabetes"},{"key":"key\n\t\t\t\t2019041114174497400_R16","doi-asserted-by":"crossref","first-page":"27030","DOI":"10.1074\/jbc.M704144200","article-title":"11\u03b2-Hydroxysteroid dehydrogenase type 1 regulation by intracellular glucose 6-phosphate provides evidence for a novel link between glucose metabolism and hypothalamo-pituitary-adrenal axis function.","volume":"282","author":"Walker","year":"2007","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t2019041114174497400_R17","doi-asserted-by":"crossref","first-page":"4647","DOI":"10.1210\/jc.2001-012045","article-title":"5\u03b1-Reductase and 11\u03b2-hydroxysteroid dehydrogenase activity in prepubertal Hispanic girls with premature adrenarche.","volume":"87","author":"Silfen","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114174497400_R18","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/j.1365-2230.2006.02146.x","article-title":"Content of 5\u03b1-reductase (type 1 and type 2) mRNA in dermal papillae from the lower abdominal region in women with hirsutism.","volume":"31","author":"Ska\u0142ba","year":"2006","journal-title":"Clin Exp Dermatol"},{"key":"key\n\t\t\t\t2019041114174497400_R19","doi-asserted-by":"crossref","first-page":"4085","DOI":"10.1210\/jc.2006-0227","article-title":"Variants in the 5\u03b1-reductase type 1 and type 2 genes are associated with polycystic ovary syndrome and the severity of hirsutism in affected women.","volume":"91","author":"Goodarzi","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114174497400_R20","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1210\/jcem-50-1-113","article-title":"Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease.","volume":"50","author":"Burghen","year":"1980","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114174497400_R21","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1365-2265.1988.tb03702.x","article-title":"Serum androstanediol glucuronide concentrations in normal and hirsute women and patients with thyroid dysfunction.","volume":"29","author":"Scanlon","year":"1988","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041114174497400_R22","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.2337\/db08-0495","article-title":"Impaired glucose tolerance and insulin resistance are associated with increased adipose 11 \u03b2-hydroxysteroid dehydrogenase type 1 expression and elevated hepatic 5\u03b1-reductase activity.","volume":"57","author":"Tomlinson","year":"2008","journal-title":"Diabetes"},{"key":"key\n\t\t\t\t2019041114174497400_R23","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1038\/oby.2005.186","article-title":"Increased A-ring reduction of glucocorticoids in obese Zucker rats: effects of insulin sensitization.","volume":"13","author":"Livingstone","year":"2005","journal-title":"Obes Res"},{"key":"key\n\t\t\t\t2019041114174497400_R24","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.fertnstert.2007.12.082","article-title":"A randomized placebo-controlled study on the effects of pioglitazone on cortisol metabolism in polycystic ovary syndrome.","volume":"91","author":"Glintborg","year":"2009","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t2019041114174497400_R25","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1055\/s-2007-1016296","article-title":"Adrenal involvement in polycystic ovary syndrome.","volume":"15","author":"Gonzalez","year":"1997","journal-title":"Semin Reprod Endocrinol"},{"key":"key\n\t\t\t\t2019041114174497400_R26","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1210\/jcem.86.3.7453","article-title":"Tissue-specific dysregulation of cortisol metabolism in human obesity.","volume":"86","author":"Rask","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114174497400_R27","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1007\/s00125-007-0629-9","article-title":"Cortisol clearance and associations with insulin sensitivity, body fat and fatty liver in middle-aged men.","volume":"50","author":"Holt","year":"2007","journal-title":"Diabetologia"},{"key":"key\n\t\t\t\t2019041114174497400_R28","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1210\/jc.2005-2222","article-title":"Genetic variation in 11\u03b2-hydroxysteroid dehydrogenase type 1 predicts adrenal hyperandrogenism among lean women with polycystic ovary syndrome.","volume":"91","author":"Gambineri","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114174497400_R29","doi-asserted-by":"crossref","first-page":"4754","DOI":"10.1210\/endo.136.11.7588203","article-title":"11\u03b2-Hydroxysteroid dehydrogenase is an exclusive 11 \u03b2-reductase in primary cultures of rat hepatocytes: effect of physicochemical and hormonal manipulations.","volume":"136","author":"Jamieson","year":"1995","journal-title":"Endocrinology"},{"key":"key\n\t\t\t\t2019041114174497400_R30","doi-asserted-by":"crossref","first-page":"12629","DOI":"10.1074\/jbc.M003592200","article-title":"Peroxisome proliferator-activated receptor-\u03b3 ligands inhibit adipocyte 11 \u03b2-hydroxysteroid dehydrogenase type 1 expression and activity.","volume":"276","author":"Berger","year":"2001","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t2019041114174497400_R31","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1046\/j.1365-2265.2000.00975.x","article-title":"Lack of relationship between 11\u03b2-hydroxysteroid dehydrogenase setpoint and insulin sensitivity in the basal state and after 24 h of insulin infusion in healthy subjects and type 2 diabetic patients.","volume":"52","author":"Kerstens","year":"2000","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041114174497400_R32","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1124\/mol.63.3.722","article-title":"Dehydroepiandrosterone affects the expression of multiple genes in rat liver including 11\u03b2-hydroxysteroid dehydrogenase type 1: a cDNA array analysis.","volume":"63","author":"Gu","year":"2003","journal-title":"Mol Pharmacol"},{"key":"key\n\t\t\t\t2019041114174497400_R33","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1210\/endo.141.2.7297","article-title":"Understanding the role of glucocorticoids in obesity: tissue-specific alterations of corticosterone metabolism in obese Zucker rats.","volume":"141","author":"Livingstone","year":"2000","journal-title":"Endocrinology"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/94\/9\/3558\/9067673\/jcem3558.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,21]],"date-time":"2019-05-21T04:46:41Z","timestamp":1558414001000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/94\/9\/3558\/2597400"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9,1]]},"references-count":33,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2009,9,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2009-0837","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,9,1]]}}}